Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Albemarle Corp (ALB) posted $1.6 billion in net sales and $646 million in adjusted EBITDA, raised its Specialties outlook, and cut 2026 capital expenditures despite softer Q4 pricing expectations.
Albemarle stock rose, as low-cost lithium has generated solid profits.
Albemarle reported better than expected Q3 adjusted earnings and pointed to strengthening lithium market fundamentals, with demand growth outpacing supply.
In the most recent trading session, Albemarle (ALB) closed at $93.27, indicating a -3.81% shift from the previous trading day.
Analysts upgraded ALB, LQDA, WY, RAL, setting or revising price targets to $130, $70, $25, $88.
This is the newest page. Registered accounts read further back.